United Asset Strategies Inc. Has $761,000 Stock Holdings in The Clorox Company $CLX

United Asset Strategies Inc. boosted its position in shares of The Clorox Company (NYSE:CLX) by 243.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,347 shares of the company’s stock after purchasing an additional 5,205 shares during the quarter. United Asset Strategies Inc.’s holdings in Clorox were worth $761,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in CLX. State Street Corp lifted its stake in Clorox by 3.5% in the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after buying an additional 282,794 shares during the period. Invesco Ltd. grew its position in shares of Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after buying an additional 884,751 shares during the period. Geode Capital Management LLC increased its stake in shares of Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after acquiring an additional 10,060 shares during the last quarter. Van ECK Associates Corp raised its position in shares of Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after acquiring an additional 426,433 shares during the period. Finally, Two Sigma Investments LP boosted its stake in Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after acquiring an additional 439,797 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CLX. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. Citigroup dropped their price objective on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Morgan Stanley reduced their target price on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Royal Bank Of Canada decreased their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. Finally, Jefferies Financial Group lowered their price target on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $103.40.

Clorox Price Performance

Shares of NYSE CLX opened at $97.45 on Wednesday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The business’s 50 day moving average price is $94.19 and its two-hundred day moving average price is $104.20. The company has a market cap of $11.78 billion, a PE ratio of 15.82, a price-to-earnings-growth ratio of 0.46 and a beta of 0.54. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the previous year, the company earned $1.45 earnings per share. The company’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Insiders Place Their Bets

In related news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.63% of the stock is owned by corporate insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.